In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
May 8th, 2008 | 28 | No |
Popular Name: Cdk1/2InhibitorIII Cdk1/2InhibitorIII
Find On: PubMed — Wikipedia — Google
CAS Number: 443798-55-8
5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.39 | 7.08 | -16.53 | 6 | 9 | 0 | 141 | 425.446 | 6 | ↓ |
Hi High (pH 8-9.5) | 2.43 | 7.94 | -52.61 | 5 | 9 | -1 | 141 | 424.438 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 8.75e-03 g/l | DrugBank-experimental |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA1-1-E | Cyclin A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
CCNA2-1-E | Cyclin A2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
CCNB1-1-E | G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
CCNB2-1-E | G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
CCNB3-1-E | G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
CDK1-3-E | Cyclin-dependent Kinase 1 (cluster #3 Of 4), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
E2AK2-1-E | Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.29 | Binding ≤ 10μM |
GSK3A-1-E | Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 140 | 0.34 | Binding ≤ 10μM |
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 140 | 0.34 | Binding ≤ 10μM |
KAPCA-1-E | CAMP-dependent Protein Kinase Alpha-catalytic Subunit (cluster #1 Of 4), Eukaryotic | Eukaryotes | 5200 | 0.26 | Binding ≤ 10μM |
KAPCB-1-E | CAMP-dependent Protein Kinase Beta-1 Catalytic Subunit (cluster #1 Of 3), Eukaryotic | Eukaryotes | 5200 | 0.26 | Binding ≤ 10μM |
KAPCG-1-E | CAMP-dependent Protein Kinase, Gamma Catalytic Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5200 | 0.26 | Binding ≤ 10μM |
KC1A-1-E | Casein Kinase I Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM |
KC1D-1-E | Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM |
KC1E-1-E | Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM |
KC1G1-1-E | Casein Kinase I Gamma 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM |
KC1G2-1-E | Casein Kinase I Gamma 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM |
KCC2A-1-E | CaM Kinase II Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8900 | 0.25 | Binding ≤ 10μM |
KCC2B-1-E | CaM Kinase II Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8900 | 0.25 | Binding ≤ 10μM |
KCC2D-1-E | CaM Kinase II Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8900 | 0.25 | Binding ≤ 10μM |
KCC2G-1-E | CaM Kinase II Gamma (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8900 | 0.25 | Binding ≤ 10μM |
PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1600 | 0.29 | Binding ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.29 | Binding ≤ 10μM |
Q95J97-1-E | CAMP-dependent Protein Kinase Alpha-catalytic Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5200 | 0.26 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 32 | 0.37 | Binding ≤ 10μM |
Z104300-1-O | Mitogen-activated Protein Kinase; ERK1/ERK2 (cluster #1 Of 1), Other | Other | 1000 | 0.30 | Binding ≤ 10μM |
Z103203-1-O | A375 (cluster #1 Of 3), Other | Other | 92 | 0.35 | Functional ≤ 10μM |
Z80018-2-O | A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other | Other | 92 | 0.35 | Functional ≤ 10μM |
Z80928-1-O | HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other | Other | 20 | 0.38 | Functional ≤ 10μM |
Z81247-1-O | HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other | Other | 35 | 0.37 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 0.5 | 0.47 | Binding ≤ 1μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 0.5 | 0.47 | Binding ≤ 1μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 0.6 | 0.46 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 0.5 | 0.47 | Binding ≤ 1μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 0.6 | 0.46 | Binding ≤ 1μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 0.6 | 0.46 | Binding ≤ 1μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 0.6 | 0.46 | Binding ≤ 1μM |
GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 140 | 0.34 | Binding ≤ 1μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 140 | 0.34 | Binding ≤ 1μM |
Z104300 | Z104300 | Mitogen-activated Protein Kinase; ERK1/ERK2 | 1000 | 0.30 | Binding ≤ 1μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 32 | 0.37 | Binding ≤ 1μM |
VGFR2_MOUSE | P35918 | Vascular Endothelial Growth Factor Receptor 2, Mouse | 32 | 0.37 | Binding ≤ 1μM |
KCC2A_HUMAN | Q9UQM7 | CaM Kinase II Alpha, Human | 8900 | 0.25 | Binding ≤ 10μM |
KCC2B_HUMAN | Q13554 | CaM Kinase II Beta, Human | 8900 | 0.25 | Binding ≤ 10μM |
KCC2D_HUMAN | Q13557 | CaM Kinase II Delta, Human | 8900 | 0.25 | Binding ≤ 10μM |
KCC2G_HUMAN | Q13555 | CaM Kinase II Gamma, Human | 8900 | 0.25 | Binding ≤ 10μM |
KAPCA_HUMAN | P17612 | CAMP-dependent Protein Kinase Alpha-catalytic Subunit, Human | 5200 | 0.26 | Binding ≤ 10μM |
Q95J97_RABIT | Q95J97 | CAMP-dependent Protein Kinase Alpha-catalytic Subunit, Rabit | 5200 | 0.26 | Binding ≤ 10μM |
KAPCB_HUMAN | P22694 | CAMP-dependent Protein Kinase Beta-1 Catalytic Subunit, Human | 5200 | 0.26 | Binding ≤ 10μM |
KAPCG_HUMAN | P22612 | CAMP-dependent Protein Kinase, Gamma Catalytic Subunit, Human | 5200 | 0.26 | Binding ≤ 10μM |
KC1A_HUMAN | P48729 | Casein Kinase I Alpha, Human | 2800 | 0.28 | Binding ≤ 10μM |
KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 2800 | 0.28 | Binding ≤ 10μM |
KC1E_HUMAN | P49674 | Casein Kinase I Epsilon, Human | 2800 | 0.28 | Binding ≤ 10μM |
KC1G1_HUMAN | Q9HCP0 | Casein Kinase I Gamma 1, Human | 2800 | 0.28 | Binding ≤ 10μM |
KC1G2_HUMAN | P78368 | Casein Kinase I Gamma 2, Human | 2800 | 0.28 | Binding ≤ 10μM |
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 0.5 | 0.47 | Binding ≤ 10μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 0.5 | 0.47 | Binding ≤ 10μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 0.6 | 0.46 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 0.5 | 0.47 | Binding ≤ 10μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 0.6 | 0.46 | Binding ≤ 10μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 0.6 | 0.46 | Binding ≤ 10μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 0.6 | 0.46 | Binding ≤ 10μM |
GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 140 | 0.34 | Binding ≤ 10μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 140 | 0.34 | Binding ≤ 10μM |
E2AK2_HUMAN | P19525 | Interferon-induced, Double-stranded RNA-activated Protein Kinase, Human | 1600 | 0.29 | Binding ≤ 10μM |
Z104300 | Z104300 | Mitogen-activated Protein Kinase; ERK1/ERK2 | 1000 | 0.30 | Binding ≤ 10μM |
PGFRA_RAT | P20786 | Platelet-derived Growth Factor Receptor Alpha, Rat | 1600 | 0.29 | Binding ≤ 10μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 1600 | 0.29 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 32 | 0.37 | Binding ≤ 10μM |
VGFR2_MOUSE | P35918 | Vascular Endothelial Growth Factor Receptor 2, Mouse | 32 | 0.37 | Binding ≤ 10μM |
Z80018 | Z80018 | A-375 (Malignant Melanoma Cells) | 92 | 0.35 | Functional ≤ 10μM |
Z103203 | Z103203 | A375 | 92 | 0.35 | Functional ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 20 | 0.38 | Functional ≤ 10μM |
Z81247 | Z81247 | HeLa (Cervical Adenocarcinoma Cells) | 35 | 0.37 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of ATR in response to replication stress | |
Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
Activation of the pre-replicative complex | |
AKT phosphorylates targets in the cytosol | |
APC truncation mutants have impaired AXIN binding | |
APC/C:Cdc20 mediated degradation of Cyclin B | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
Ca2+ pathway | |
CDK-mediated phosphorylation and removal of Cdc6 | |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
Circadian Clock | |
Condensation of Prometaphase Chromosomes | |
Condensation of Prophase Chromosomes | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation through the activation of Adenylate Cyclase | |
CREB phosphorylation through the activation of CaMKII | |
CREB phosphorylation through the activation of Ras | |
CRMPs in Sema3A signaling | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin B2 mediated events | |
Cyclin E associated events during G1/S transition | |
DARPP-32 events | |
Degradation of beta-catenin by the destruction complex | |
Depolymerisation of the Nuclear Lamina | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
DNA Damage/Telomere Stress Induced Senescence | |
Downstream signal transduction | |
E2F mediated regulation of DNA replication | |
E2F-enabled inhibition of pre-replication complex formation | |
EPHA-mediated growth cone collapse | |
ERK1 activation | |
Factors involved in megakaryocyte development and platelet production | |
G0 and Early G1 | |
G1/S-Specific Transcription | |
G2 Phase | |
G2/M DNA replication checkpoint | |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | |
Gluconeogenesis | |
Golgi Cisternae Pericentriolar Stack Reorganization | |
Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |
HSF1-dependent transactivation | |
Inhibition of PKR | |
Integrin cell surface interactions | |
Interferon gamma signaling | |
Interleukin-3, 5 and GM-CSF signaling | |
ISG15 antiviral mechanism | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MASTL Facilitates Mitotic Progression | |
Meiotic recombination | |
misspliced GSK3beta mutants stabilize beta-catenin | |
Neurophilin interactions with VEGF and VEGFR | |
Nuclear Pore Complex (NPC) Disassembly | |
Orc1 removal from chromatin | |
p53-Dependent G1 DNA Damage Response | |
Phosphorylation of Emi1 | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
Phosphorylation of the APC/C | |
PIP3 activates AKT signaling | |
PKA activation | |
PKA activation in glucagon signalling | |
PKA-mediated phosphorylation of CREB | |
PKA-mediated phosphorylation of key metabolic factors | |
Polo-like kinase mediated events | |
Rap1 signalling | |
Ras activation uopn Ca2+ infux through NMDA receptor | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of HSF1-mediated heat shock response | |
Regulation of insulin secretion | |
Regulation of PLK1 Activity at G2/M Transition | |
Resolution of Sister Chromatid Cohesion | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
Signaling by PDGF | |
Sphingolipid de novo biosynthesis | |
T41 mutants of beta-catenin aren't phosphorylated | |
Trafficking of AMPA receptors | |
truncations of AMER1 destabilize the destruction complex | |
Unblocking of NMDA receptor, glutamate binding and activation | |
Vasopressin regulates renal water homeostasis via Aquaporins | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation | |
WNT mediated activation of DVL | |
XBP1(S) activates chaperone genes |
No pre-computed analogs available. Try a structural similarity search.